Literature DB >> 10869326

Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici.

D Fedele1, A Bortolotti, C Coscelli, F Santeusanio, L Chatenoud, E Colli, M Lavezzari, M Landoni, F Parazzini.   

Abstract

BACKGROUND: Several studies reported data on the increased risk of erectile dysfunction (ED) in populations of diabetic men, but few presented data separately for Type 1 and Type 2 subjects. No comparison data for these diabetic subgroups are available with regard to risk factors for ED.
METHODS: Eligible for the study were men aged 20-69 years with a diagnosis of insulin-dependent (Type 1) or non-insulin-dependent (Type 2) diabetes who were observed on randomly selected days in 178 diabetes centres in Italy. Erectile dysfunction was defined as a failure to achieve and maintain an erection sufficient for satisfactory sexual performance.
RESULTS: The study population consisted of 1383 Type 1 and 8373 Type 2 men. The prevalence of ED increased with age for both groups. After taking into account the effect of age Type 2 men (37/100 men) tend to report ED less frequently than Type 1 men (51/100 men). A significant positive relationship was reported between ED and poor metabolic control and smoking for both Type 1 and Type 2 men, whereas high body mass index (BMI) increased only the risk of ED in Type 1 cases.
CONCLUSIONS: The study offers a quantitative estimate of the prevalence of ED and its main risk factors in Type 1 and Type 2 diabetic subgroups.

Entities:  

Mesh:

Year:  2000        PMID: 10869326

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  30 in total

1.  Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes.

Authors:  Neha Singh; Goutham Vasam; Rahul Pawar; Yagna P R Jarajapu
Journal:  J Sex Med       Date:  2014-06-23       Impact factor: 3.802

2.  Exercise training improves the defective centrally mediated erectile responses in rats with type I diabetes.

Authors:  Hong Zheng; William G Mayhan; Kaushik P Patel
Journal:  J Sex Med       Date:  2011-08-24       Impact factor: 3.802

3.  Erectile Dysfunction and Other Sexual Activity Dysfunctions among Saudi Type 2 Diabetic Patients.

Authors:  Turki Abdullah AlMogbel
Journal:  Int J Health Sci (Qassim)       Date:  2014-10

4.  Sexual dysfunction among diabetics and its impact on the SQoL of their partners.

Authors:  W K B A Owiredu; H Alidu; N Amidu; C Obirikorang; C K Gyasi-Sarpong; A T Bawah; P P M Dapare; A T Luuse
Journal:  Int J Impot Res       Date:  2017-08-17       Impact factor: 2.896

5.  Four-year review of sildenafil citrate.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2002

6.  Prevalence and Severity of Erectile Dysfunction as Assessed by IIEF-5 in North Indian Type 2 Diabetic Males and Its Correlation with Variables.

Authors:  Arvind Goyal; Parminder Singh; Ashish Ahuja
Journal:  J Clin Diagn Res       Date:  2013-12-15

7.  Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.

Authors:  R González-Corrochano; Jm La Fuente; P Cuevas; A Fernández; Mx Chen; I Sáenz de Tejada; J Angulo
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 8.  Obstructive sleep apnea and erectile dysfunction: still a neglected risk factor?

Authors:  Nikolaos Zias; Vishnu Bezwada; Sean Gilman; Alexandra Chroneou
Journal:  Sleep Breath       Date:  2008-09-03       Impact factor: 2.816

9.  The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.

Authors:  G Corona; C B Giorda; D Cucinotta; P Guida; E Nada
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

10.  Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort.

Authors:  Paul Enzlin; Raymond Rosen; Markus Wiegel; Jeanette Brown; Hunter Wessells; Patricia Gatcomb; Brandy Rutledge; Ka-Ling Chan; Patricia A Cleary
Journal:  Diabetes Care       Date:  2009-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.